Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:35 PM ET 10-Q
Financial Results Adm Endeavors, Inc. ADMQ

Adm Endeavors Q3 2026 Results: Net Income $197K, Down 8.7% YoY

ADM Endeavors, Inc. reported total revenue of $4.58 million for the nine months ended September 30, 2026, a slight increase from $4.31 million in the prior year period. The company achieved a net income of $127,075 for the first nine months of 2026, down from $250,321 in 2025, primarily due to significantly higher interest expenses and the absence of a large gain on an insurance claim seen in the previous year.

Key figure
Net income $197K · -8.7% YoY
4:35 PM ET Form 4
Insider Selling Editas Medicine, Inc. EDIT

Editas Medicine CEO Gilmore Neil O'Neill Sells $51.1K of Stock

Gilmore Neil O'Neill, CEO, sold 21,164 shares of Editas Medicine, Inc. at $2.42 a share, worth $51.1K in total on Nov 11, 2026. Shares held after the trade: 265,592 (-7.4%).

Value
$51.1K
Shares
21,164
Price
$2.42
Role
CEO
Holding change
-7.4%
Trade date
Nov 11, 2026
4:34 PM ET Form 4
Insider Buying General American Investors Co Inc GAM

General American Investors Co VP Administration Eugene S. Stark Buys $88K of Stock

Eugene S. Stark, VP Administration, bought 4,000 shares of General American Investors Co Inc at $22.00 a share, worth $88K in total on Nov 13, 2026. Shares held after the trade: 5,000 (+25.0%).

Value
$88K
Shares
4,000
Average price
$22.00
Role
VP Administration
Holding change
+25.0%
Trade date
Nov 13, 2026
4:34 PM ET 10-Q
Financial Results Forbright, Inc. FRBT

Forbright Q3 2026 Results: Net Income $20.6M, Down 35.7% YoY

Forbright, Inc. filed its 10-Q for the period ending September 30, 2026, reporting 33,601,078 shares of Class A common stock outstanding. The filing highlights a pending branch sale agreement and the adoption of the 2026 Omnibus Incentive Plan, while emphasizing risks related to AI implementation and credit quality.

Key figure
Net income $20.6M · -35.7% YoY
4:34 PM ET 8-K
Loan & Debt Avita Medical, Inc. RCEL

Avita Medical Debt Financing Update with Perceptive Credit Holdings V, LP

AVITA Medical reported the exercise of warrants by lenders Perceptive Credit Holdings and OrbiMed under existing credit agreements. Both exercises were conducted on a cashless basis, resulting in the issuance of 119,375 and 148,158 shares of common stock, respectively. These transactions represent the settlement of equity obligations tied to previously established debt facilities.

Counterparty
Perceptive Credit Holdings V, LP
4:34 PM ET 10-Q
Financial Results Churchill Capital Corp XI AGLT

Agility Robotics Q3 2026 Results: Turns Profitable, Net Income $109M

Churchill Capital Corp XI (CCXI) completed its business combination with Legacy Agility on November 2, 2026, subsequently changing its name to Agility Robotics, Inc. The filing covers the period ended September 30, 2026, prior to the merger's consummation, and reflects a pre-money equity value for Legacy Agility of $2.5 billion.

Key figure
Net income $109M
4:34 PM ET Form 4
Insider Selling Butterfly Network, Inc. BFLY

Butterfly Network EVP, CFO John N. Doherty Sells $350K of Stock

John N. Doherty, EVP, CFO, sold 50,000 shares of Butterfly Network, Inc. at $7.00 a share, worth $350K in total on Nov 11, 2026. Shares held after the trade: 1,347,276 (-3.6%).

Value
$350K
Shares
50,000
Price
$7.00
Role
EVP, CFO
Holding change
-3.6%
Trade date
Nov 11, 2026
4:34 PM ET Form 4
Insider Selling Cushman & Wakefield Ltd. CWK

Cushman & Wakefield Insider Nathaniel Robinson Sells $175K of Stock

Nathaniel Robinson sold 12,518 shares of Cushman & Wakefield Ltd. at $13.98 a share, worth $175K in total on Nov 10, 2026. Shares held after the trade: 45,858 (-21.4%).

Value
$175K
Shares
12,518
Price
$13.98
Holding change
-21.4%
Trade date
Nov 10, 2026
4:34 PM ET 10-Q
Financial Results Nexpoint Diversified Real Estate Trust NXDT

Nexpoint Diversified Real Estate Trust Q3 2026 Results: Net Loss of $55.5M, Loss Widens

NexPoint Diversified Real Estate Trust reported total assets of $993.4 million as of September 30, 2026, a decrease from $1.07 billion at year-end 2025. The company experienced a significant increase in its accumulated loss to $458.2 million, while total shareholders' equity declined from $700.1 million to $610.6 million during the nine-month period.

Key figure
Net loss $55.5M
4:34 PM ET 8-K
Dividend Columbia Banking System, Inc. COLB

Columbia Banking System Dividend

Columbia Banking System's Board of Directors approved a quarterly cash dividend of $0.38 per common share, representing a 3% increase over the previous declaration. The dividend is payable on December 14, 2026, to shareholders of record as of November 27, 2026.

4:34 PM ET 8-K
Loan & Debt Blue Owl Technology Income Corp. OTIC

Blue Owl Technology Income Debt Financing Update with Citibank, N.A.

Blue Owl Technology Income Corp.'s subsidiary, Tech Income Funding II LLC, entered into Amendment No. 3 to its senior secured revolving credit facility with Citibank, N.A. as administrative agent. The amendment primarily aligns the 'Determination Date' to the end of each calendar month for the facility originally dated May 31, 2023.

Counterparty
Citibank, N.A.
4:34 PM ET Form 4
Insider Selling Editas Medicine, Inc. EDIT

Editas Medicine EVP, CSO Linda Burkly Sells $18.9K of Stock

Linda Burkly, EVP, CSO, sold 7,814 shares of Editas Medicine, Inc. at $2.42 a share, worth $18.9K in total on Nov 11, 2026. Shares held after the trade: 70,379 (-10.0%).

Value
$18.9K
Shares
7,814
Price
$2.42
Role
EVP, CSO
Holding change
-10.0%
Trade date
Nov 11, 2026
4:34 PM ET 8-K
Loan & Debt WhiteHorse Finance, Inc. WHF

WhiteHorse Finance $34.5M Debt Financing with Equiniti Trust Company, LLC

WhiteHorse Finance, Inc. has notified its trustee of its election to redeem the entire $34.5 million aggregate principal amount of its 7.875% Notes due 2028. The redemption is expected to be completed on December 15, 2026, at a price of $25 per note plus accrued interest, after which the notes will be delisted from Nasdaq. The company intends to fund the redemption using proceeds from additional indebtedness.

Value
$34.5M
Counterparty
Equiniti Trust Company, LLC
4:34 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $587.00 to $597.33 a share (average $593.52) in 11 transactions, worth $5.64M in total on Nov 12, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.64M
Shares
9,500
Average price
$593.52
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 12, 2026
4:34 PM ET Form 4
Insider Selling XPO, Inc. XPO

XPO CAO Christopher Michael Brown Sells $331K of Stock

Christopher Michael Brown, CAO, sold 1,750 shares of XPO, Inc. at $188.16 to $193.11 a share (average $189.33) in 4 transactions, worth $331K in total on Nov 12, 2026. Shares held after the trade: 29,255 (-0.3%).

Value
$331K
Shares
1,750
Average price
$189.33
Role
CAO
Holding change
-0.3%
Trade date
Nov 12, 2026
4:34 PM ET Form 4
Insider Buying Babcock & Wilcox Enterprises, Inc. BW

Babcock & Wilcox Enterprises Insider Philip D. Moeller Buys $14K of Stock

Philip D. Moeller bought 3,000 shares of Babcock & Wilcox Enterprises, Inc. at $4.65 a share, worth $14K in total on Nov 12, 2026. Shares held after the trade: 243,809 (+1.2%).

Value
$14K
Shares
3,000
Price
$4.65
Holding change
+1.2%
Trade date
Nov 12, 2026
4:34 PM ET Form 4
Insider Selling Church & Dwight Co Inc CHD

Church & Dwight Co Insider Janet S. Vergis Sells $1.3M of Stock

Janet S. Vergis sold 11,590 shares of Church & Dwight Co Inc at $112.00 a share, worth $1.3M in total on Nov 11, 2026. Shares held after the trade: 21,188 (-35.4%).

Value
$1.3M
Shares
11,590
Price
$112.00
Holding change
-35.4%
Trade date
Nov 11, 2026
4:34 PM ET 10-Q
Financial Results Broadway Financial Corp \De\ BYFC

Broadway Financial Corp \De\ Q3 2026 Results: Turns Profitable, Net Income $1.14M

Broadway Financial Corp reported net income of $1.1 million for the third quarter of 2026, a significant recovery from a $23.9 million loss in the prior year period which was driven by a $25.9 million goodwill impairment. Total assets grew to $1.56 billion as of September 30, 2026, primarily fueled by a $192.4 million increase in deposits and growth in the loan portfolio.

Key figure
Net income $1.14M
4:34 PM ET 10-Q
Financial Results Air T Inc AIRT

Air T Q2 2026 Results: Net Loss of $20M

Air T Inc. reported a significant increase in operating revenues to $262.4 million for the six months ended September 30, 2026, driven by the addition of regional airline and aviation leasing segments. However, the company swung to a net loss of $35.2 million compared to a profit in the prior year, primarily due to higher operating expenses, increased interest costs, and a $3.4 million earnout remeasurement charge.

Key figure
Net loss $20M
4:34 PM ET 10-Q
Financial Results Kpet Ultra Paceline Corp KPET

Kpet Ultra Paceline Q3 2026 Results: Turns Profitable, Net Income $1.95M

KPET Ultra Paceline Corp reported net income of $3.53 million for the nine months ended September 30, 2026, primarily driven by $4.08 million in interest earned on investments held in the Trust Account. As a shell company, its primary assets consist of $233.8 million in the Trust Account, while it maintains a shareholders' deficit of $11.23 million due to the accretion of Class A ordinary shares to redemption value.

Key figure
Net income $1.95M
4:34 PM ET 10-Q
Financial Results Golden Minerals Co AUMN

Golden Minerals Q3 2026 Results: Net Loss of $750K, Loss Narrows

Golden Minerals Company reported a net loss of $0.7 million for the nine months ended September 30, 2026, an improvement from a $3.0 million loss in the prior year period, primarily due to $1.1 million in income from discontinued operations. The company remains in the exploration stage with no mineral reserves, maintaining a cash balance of $1.7 million as of the end of the third quarter.

Key figure
Net loss $750K
4:34 PM ET 10-Q
Financial Results Moleculin Biotech, Inc. MBRX

Moleculin Biotech Q3 2026 Results: Net Loss of $6.49M, Loss Narrows

Moleculin Biotech reported a net loss of $27.0 million for the nine months ended September 30, 2026, compared to a $49.1 million loss in the prior year period. The company ended the quarter with $7.3 million in cash and cash equivalents, supported by $20.3 million in net cash provided by financing activities during the year.

Key figure
Net loss $6.49M
4:33 PM ET 10-Q
Financial Results Silo Pharma, Inc. SILO

Silo Pharma Q3 2026 Results: Net Loss of $359K, Loss Narrows

For the nine months ended September 30, 2026, Silo Pharma reported a net loss of $2.84 million, an improvement from the $3.35 million loss in the prior year period. The company's cash position increased to $6.09 million, bolstered by a $0.70 million gain from the termination of a sublicense agreement and financing activities.

Key figure
Net loss $359K
4:33 PM ET 10-Q
Financial Results RMG ML Sports Holdings SHOT

RMG ML Sports Holdings Q3 2026 Results: Net Income $1.91M

RMG ML Sports Holdings reported a net loss of $4.30 million for the nine months ended September 30, 2026, primarily driven by $6.79 million in general and administrative expenses. As a shell company, its assets are largely comprised of $218.92 million held in a Trust Account following its initial public offering in mid-2026.

Key figure
Net income $1.91M
4:33 PM ET 10-Q
Financial Results Graf Global Corp. TONT

Graf Global Q3 2026 Results: Net Loss of $5.25K

For the nine months ended September 30, 2026, Graf Global Corp. reported net income of $1,588,180, driven by $5,076,172 in interest earned on trust account funds. The company experienced significant redemptions during the period, with $158,489,876 withdrawn from the Trust Account to redeem Class A ordinary shares.

Key figure
Net loss $5.25K
4:33 PM ET 10-Q
Financial Results Cirtran Corp CIRX

Cirtran Q3 2026 Results: Net Loss of $285K, Loss Narrows

CirTran Corporation reported a significant turnaround for the nine months ended September 30, 2026, with net income of $1,827,615 compared to a net loss of $1,138,064 in the prior year, primarily driven by income from discontinued operations. Net sales increased substantially to $2,996,530 from $1,077,743, although the company continues to carry a significant stockholders' deficit of over $23 million.

Key figure
Net loss $285K
4:33 PM ET 10-Q
Financial Results Rmx Industries, Inc. RMXI

Rmx Industries Q3 2026 Results: Net Loss of $2.34M, Loss Narrows

RMX Industries, Inc. reported a net loss of $19.4 million for the nine months ended September 30, 2026, compared to a $15.0 million loss in the prior year period, driven largely by $10.4 million in losses on warrant conversions. Revenue significantly declined to $3,722 from $311,344 year-over-year as the company pivoted its focus toward physical-edge intelligence and VAST technology.

Key figure
Net loss $2.34M
4:33 PM ET 10-Q
Financial Results Fabric.AI, Inc. FABC

Fabric.AI Q3 2026 Results: Net Loss of $4.91M, Loss Widens

Fabric.AI, Inc. reported a net loss of $19.8 million for the nine months ended September 30, 2026, compared to a $16.1 million loss in the prior year period. The company significantly increased its research and development spending to $10.2 million and ended the quarter with $39.2 million in total assets, largely driven by new issuances of Series J and K convertible preferred stock.

Key figure
Net loss $4.91M
4:33 PM ET 8-K
Financial Results Newton Golf Company, Inc. NWTG

Newton Golf Company Financial Results

Newton Golf Company reported Q3 2026 net sales of $1.4 million, a decline from $2.6 million in the prior year due to marketing agency transitions and strategy changes. Despite lower revenue, the company improved its net loss to $1.2 million compared to $1.6 million in the prior-year quarter, driven by reduced operating expenses. Subsequent to the quarter-end, the company strengthened its balance sheet by raising approximately $3.0 million in net proceeds from equity financings.

Term
Q3 2026
4:33 PM ET Form 4
Insider Selling Luckin Coffee Inc. LKNCY

Luckin Coffee SVP Wenbao Cao Sells $5.38M of Stock

Wenbao Cao, SVP, sold 150,000 shares of Luckin Coffee Inc. at $35.89 a share, worth $5.38M in total on Nov 10, 2026. Shares held after the trade: 1,035,701 (-12.7%).

Value
$5.38M
Shares
150,000
Price
$35.89
Role
SVP
Holding change
-12.7%
Trade date
Nov 10, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.